Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$222,737
+$27,746 QoQ
Shares Held
1,763
-26.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,861
of 2,266 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resurgent Financial Advisors LLC holds $18,383,670 across 8 Drug Manufacturers - General names. GILD ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,580 | $6,692,819 | |
| 2 | JNJ |
Johnson & Johnson
|
22,360 | $5,678,769 | |
| 3 | AMGN |
Amgen Inc
|
4,679 | $1,694,359 | |
| 4 | ABBV |
AbbVie Inc.
|
5,944 | $1,495,748 | |
| 5 | PFE |
Pfizer Inc
|
52,559 | $1,265,620 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,331 | $942,033 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,796 | $391,585 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,763 | $222,737 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,737 | 1,763 | Shares | Sole | 2026-08-14 | |
| 2023-12-31 | $194,991 | 2,407 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $160,671 | 2,144 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $159,149 | 2,065 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $175,315 | 2,113 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $362,973 | 4,228 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $275,322 | 4,463 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $204,838 | 3,314 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $289,699 | 4,873 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||